Parents associated with children in measuring acute and delayed nausea and vomiting

L H Lo1, L L Hayman

  • 1School of Nursing, Medical College, National Cheng Kung University, Tainan, Taiwan. lhlo@mail.ncku.edu.tw

Insights

Parents accurately assess children's chemotherapy side effects. Their observations of nausea and vomiting align closely with children's self-reports, aiding symptom management.

Area of Science:

  • Oncology
  • Pediatrics
  • Nursing

Background:

  • Cancer chemotherapy often causes acute and delayed nausea and vomiting in children.
  • Accurate symptom assessment is crucial for effective management and supportive care.
  • Parental involvement in symptom monitoring can enhance care quality.

Purpose of the Study:

  • To examine the relationship between parents' and children's reports of chemotherapy-induced nausea and vomiting (CINV).
  • To determine the reliability and validity of parental assessment of pediatric CINV.
  • To understand the concordance between child self-report and parent proxy-report of CINV.

Main Methods:

  • Utilized the Adapted Rhodes Index of Nausea and Vomiting for both parent and child (aged 8-18 years).
  • Collected data every 12 hours over three days from 20 parent-child dyads.
  • Employed correlational analysis to assess the association between parent and child symptom scores.

Main Results:

  • Found significant moderate to strong associations between parent and child total scores (r = 0.85-0.93, P < 0.01).
  • Observed strong correlations for nausea (r = 0.67-0.93, P < 0.01) and vomiting scores (r = 0.91-0.99, P < 0.01).
  • Demonstrated high concordance between child self-reports and parental observations.

Conclusions:

  • Parents' observations of their children's CINV are strongly associated with the child's self-report.
  • Parents can reliably assess acute and delayed nausea and vomiting in pediatric cancer patients.
  • Parental monitoring is a valuable tool in managing CINV in children undergoing chemotherapy.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through interaction...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...